Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07463053 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers

StatusNot Yet Recruiting
PhasePhase 1
SponsorJemincare
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 10, 2026 (before its estimated May 7, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Jemincare
23 trials monitored
See all monitored trials
A phase 1 healthy volunteer study to assess the excretion and metabolism as well as the absolute bioavailability of oral JMKX003142. The study will be conducted in two parts: Part 1 to assess the mass balance of JMKX003142 using orally administered radiolabelled JMKX003142; part 2 will assess the absolute bioavailability using JMKX003142 and radiolabelled JMKX003142 as intravenous and oral forms
Trial Details
NCT Number NCT07463053
Lead Sponsor Jemincare
Collaborators: Zhejiang Hangyu Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Related terms Polycystic Kidney, Autosomal Dominant
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov